List of Excipients in API cisatracurium besylate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing cisatracurium besylate
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
AbbVie Inc | NIMBEX | cisatracurium besylate | 0074-4382 | BENZENESULFONIC ACID | |
AbbVie Inc | NIMBEX | cisatracurium besylate | 0074-4382 | WATER | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing cisatracurium besylate
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Hikma Pharmaceuticals USA Inc | cisatracurium besylate | 0143-9396 | BENZENESULFINIC ACID |
Hikma Pharmaceuticals USA Inc | cisatracurium besylate | 0143-9396 | WATER |
Hikma Pharmaceuticals USA Inc | cisatracurium besylate | 0143-9397 | BENZENESULFINIC ACID |
Hikma Pharmaceuticals USA Inc | cisatracurium besylate | 0143-9397 | BENZYL ALCOHOL |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for cisatracurium besylate
Excipient focus: BENZENESULFINIC ACID
cisatracurium besylate drug variants containing BENZENESULFINIC ACID
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | cisatracurium besylate | 0143-9396 |
Hikma Pharmaceuticals USA Inc | cisatracurium besylate | 0143-9397 |
Hikma Farmaceutica | cisatracurium besylate | 62778-165 |
>Company | >Ingredient | >NDC |
cisatracurium besylate drug variants not containing BENZENESULFINIC ACID
Company | Ingredient | NDC |
---|---|---|
AbbVie Inc | cisatracurium besylate | 0074-4382 |
Hospira Inc | cisatracurium besylate | 0409-1098 |
Hospira Inc | cisatracurium besylate | 0409-5547 |
Teva Parenteral Medicines Inc | cisatracurium besylate | 0703-2033 |
>Company | >Ingredient | >NDC |
Excipient focus: BENZENESULFONIC ACID
cisatracurium besylate drug variants containing BENZENESULFONIC ACID
Company | Ingredient | NDC |
---|---|---|
AbbVie Inc | cisatracurium besylate | 0074-4382 |
Hospira Inc | cisatracurium besylate | 0409-1098 |
Hospira Inc | cisatracurium besylate | 0409-5547 |
Teva Parenteral Medicines Inc | cisatracurium besylate | 0703-2033 |
>Company | >Ingredient | >NDC |
cisatracurium besylate drug variants not containing BENZENESULFONIC ACID
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | cisatracurium besylate | 0143-9396 |
Hikma Pharmaceuticals USA Inc | cisatracurium besylate | 0143-9397 |
Hikma Farmaceutica | cisatracurium besylate | 62778-165 |
>Company | >Ingredient | >NDC |
Excipient focus: BENZYL ALCOHOL
cisatracurium besylate drug variants containing BENZYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | cisatracurium besylate | 0143-9397 |
Teva Parenteral Medicines Inc | cisatracurium besylate | 0703-2056 |
Sandoz Inc | cisatracurium besylate | 0781-3152 |
Sandoz Inc | cisatracurium besylate | 0781-9038 |
>Company | >Ingredient | >NDC |
cisatracurium besylate drug variants not containing BENZYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
AbbVie Inc | cisatracurium besylate | 0074-4382 |
Hikma Pharmaceuticals USA Inc | cisatracurium besylate | 0143-9396 |
Hospira Inc | cisatracurium besylate | 0409-1098 |
Hospira Inc | cisatracurium besylate | 0409-5547 |
>Company | >Ingredient | >NDC |
Excipient focus: NITROGEN
cisatracurium besylate drug variants containing NITROGEN
Company | Ingredient | NDC |
---|---|---|
Caplin Steriles Limited | cisatracurium besylate | 65145-135 |
>Company | >Ingredient | >NDC |
cisatracurium besylate drug variants not containing NITROGEN
Company | Ingredient | NDC |
---|---|---|
AbbVie Inc | cisatracurium besylate | 0074-4382 |
Hikma Pharmaceuticals USA Inc | cisatracurium besylate | 0143-9396 |
Hikma Pharmaceuticals USA Inc | cisatracurium besylate | 0143-9397 |
Hospira Inc | cisatracurium besylate | 0409-1098 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
cisatracurium besylate drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
AbbVie Inc | cisatracurium besylate | 0074-4382 |
Hikma Pharmaceuticals USA Inc | cisatracurium besylate | 0143-9396 |
Hikma Pharmaceuticals USA Inc | cisatracurium besylate | 0143-9397 |
Hospira Inc | cisatracurium besylate | 0409-1098 |
>Company | >Ingredient | >NDC |
cisatracurium besylate drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
Sagent Pharmaceuticals | cisatracurium besylate | 25021-668 |
Fresenius Kabi USA LLC | cisatracurium besylate | 63323-416 |
PIRAMAL CRITICAL CARE INC | cisatracurium besylate | 66794-245 |
Meitheal Pharmaceuticals Inc | cisatracurium besylate | 71288-712 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.